GALT Financials

Galectin Therapeutics Inc - Financial statements & key metrics

Stock Price

$2.45

Market Cap

$150.09M

EPS

$-0.48

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-47.05M

EPS (Diluted)

$-0.76

Balance Sheet Highlights

Total Assets

$17.50M

Total Liabilities

$120.56M

Shareholders Equity

Cash & Equivalents

$15.12M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-41.77M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-37.3%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is GALT revenue?

View GALT's income statement for detailed revenue data.

Is GALT profitable?

GALT reported a loss of $47.05M in the most recent quarter.

What is GALT market cap?

GALT has a market capitalization of $150.09M, making it a small-cap stock.

Does GALT have debt?

View GALT's balance sheet for debt information.

What is GALT cash flow?

Cash flow data is available in the full financial statements.